Frontiers in Microbiology,
Год журнала:
2021,
Номер
12
Опубликована: Март 23, 2021
Metagenomics
is
a
segment
of
conventional
microbial
genomics
dedicated
to
the
sequencing
and
analysis
combined
genomic
DNA
entire
environmental
samples.
The
most
critical
step
metagenomic
data
reconstruction
individual
genes
genomes
microorganisms
in
communities
using
assemblers
–
computational
programs
that
put
together
small
fragments
sequenced
generated
by
instruments.
Here,
we
describe
challenges
assembly,
wide
spectrum
applications
which
assemblies
were
used
better
understand
ecology
evolution
ecosystems,
present
one
efficient
assemblers,
SPAdes
was
upgraded
become
applicable
for
metagenomics.
Nature Methods,
Год журнала:
2022,
Номер
19(4), С. 429 - 440
Опубликована: Апрель 1, 2022
Abstract
Evaluating
metagenomic
software
is
key
for
optimizing
metagenome
interpretation
and
focus
of
the
Initiative
Critical
Assessment
Metagenome
Interpretation
(CAMI).
The
CAMI
II
challenge
engaged
community
to
assess
methods
on
realistic
complex
datasets
with
long-
short-read
sequences,
created
computationally
from
around
1,700
new
known
genomes,
as
well
600
plasmids
viruses.
Here
we
analyze
5,002
results
by
76
program
versions.
Substantial
improvements
were
seen
in
assembly,
some
due
long-read
data.
Related
strains
still
challenging
assembly
genome
recovery
through
binning,
was
quality
latter.
Profilers
markedly
matured,
taxon
profilers
binners
excelling
at
higher
bacterial
ranks,
but
underperforming
viruses
Archaea.
Clinical
pathogen
detection
revealed
a
need
improve
reproducibility.
Runtime
memory
usage
analyses
identified
efficient
programs,
including
top
performers
other
metrics.
identify
challenges
guide
researchers
selecting
analyses.
Clinical Infectious Diseases,
Год журнала:
2020,
Номер
72(2), С. 239 - 245
Опубликована: Янв. 13, 2020
Metagenomic
next-generation
sequencing
(mNGS)
of
plasma
cell-free
DNA
has
emerged
as
an
attractive
diagnostic
modality
allowing
broad-range
pathogen
detection,
noninvasive
sampling,
and
earlier
diagnosis.
However,
little
is
known
about
its
real-world
clinical
impact
used
in
routine
practice.We
performed
a
retrospective
cohort
study
all
patients
for
whom
mNGS
(Karius
test)
was
indications
at
5
United
States
institutions
over
1.5
years.
Comprehensive
records
review
performed,
standardized
assessment
the
based
on
treating
team's
interpretation
Karius
results
patient
management
established.A
total
82
tests
were
evaluated
from
39
(47.6%)
adults
43
(52.4%)
children
53
(64.6%)
immunocompromised
patients.
positivity
rate
50
(61.0%),
with
25
(50.0%)
showing
2
or
more
organisms
(range,
2-8).
The
test
led
to
positive
6
(7.3%),
negative
3
(3.7%),
no
71
(86.6%),
indeterminate
(2.4%).
Cases
result
involved
bacteria
and/or
fungi
but
not
viruses
parasites.
In
10
who
underwent
16
additional
repeated
tests,
only
1
associated
impact.The
currently
practice
limited.
Further
studies
are
needed
identify
high-yield
populations,
define
complementary
role
conventional
microbiological
methods,
discern
how
best
integrate
into
current
testing
algorithms.
Abstract
Background
Species-level
genetic
characterization
of
complex
bacterial
communities
has
important
clinical
applications
in
both
diagnosis
and
treatment.
Amplicon
sequencing
the
16S
ribosomal
RNA
(rRNA)
gene
proven
to
be
a
powerful
strategy
for
taxonomic
classification
bacteria.
This
study
aims
improve
method
full-length
rRNA
analysis
using
nanopore
long-read
sequencer
MinION™.
We
compared
it
conventional
short-read
mock
community
human
fecal
samples.
Results
modified
our
existing
protocol
amplicon
by
A
new
library
construction
with
an
optimized
primer
set
overcame
PCR-associated
bias
enabled
across
broad
range
species.
performance
gut
microbiota
composition.
The
relative
abundance
dominant
genera
was
highly
similar
between
sequencing.
At
species
level,
MinION™
had
better
resolution
discriminating
members
particular
taxa
such
as
Bifidobacterium
,
allowing
accurate
representation
sample
Conclusions
Our
present
microbiome
study,
comparing
discriminatory
power
sequencing,
clearly
illustrated
analytical
advantage
gene.
Abstract
Trap-based
surveillance
strategies
are
widely
used
for
monitoring
of
invasive
insect
species,
aiming
to
detect
newly
arrived
exotic
taxa
as
well
track
the
population
levels
established
or
endemic
pests.
Where
these
traps
have
low
specificity
and
capture
non-target
species
in
excess
target
pests,
need
extensive
specimen
sorting
identification
creates
a
major
diagnostic
bottleneck.
While
recent
development
standardized
molecular
diagnostics
has
partly
alleviated
this
requirement,
single
per
reaction
nature
methods
does
not
readily
scale
sheer
number
insects
trapped
programmes.
Consequently,
lists
often
restricted
few
high-priority
allowing
unanticipated
avoid
detection
potentially
establish
populations.
DNA
metabarcoding
recently
emerged
method
conducting
simultaneous,
multi-species
complex
mixed
communities
may
lend
itself
ideally
rapid
bulk
trap
samples.
Moreover,
high-throughput
sequencing
platforms
could
enable
multiplexing
hundreds
diverse
samples
on
flow
cell,
thereby
providing
means
dramatically
up
terms
both
quantity
that
can
be
processed
concurrently
pest
targeted.
In
review
literature,
we
explore
how
tailored
context
highlight
unique
technical
regulatory
challenges
must
considered
when
implementing
technologies
into
sensitive
applications.
Antibiotics,
Год журнала:
2020,
Номер
9(12), С. 877 - 877
Опубликована: Дек. 8, 2020
The
high
clinical
mortality
and
economic
burden
posed
by
invasive
fungal
infections
(IFIs),
along
with
significant
agricultural
crop
loss
caused
various
species,
has
resulted
in
the
widespread
use
of
antifungal
agents.
Selective
drug
pressure,
attributes,
host-
drug-related
factors
have
counteracted
efficacy
limited
systemic
drugs
changed
epidemiological
landscape
IFIs.
Species
belonging
to
Candida,
Aspergillus,
Cryptococcus,
Pneumocystis
are
among
pathogens
showing
notable
rates
resistance.
Drug-resistant
fungi
from
environment
increasingly
identified
settings.
Furthermore,
we
a
understanding
class-specific
resistance
mechanisms
emerging
Candida
species.
establishment
stewardship
programs
both
fields
inclusion
species
identification,
susceptibility
testing,
therapeutic
monitoring
practices
clinic
can
minimize
emergence
drug-resistant
fungi.
New
featuring
promising
profiles
great
promise
treat
setting.
Mitigating
tolerance,
prelude
resistance,
also
requires
development
effective
fungal-specific
adjuvants
be
used
combination
antifungals.
Briefings in Bioinformatics,
Год журнала:
2020,
Номер
22(2), С. 616 - 630
Опубликована: Окт. 8, 2020
Various
next
generation
sequencing
(NGS)
based
strategies
have
been
successfully
used
in
the
recent
past
for
tracing
origins
and
understanding
evolution
of
infectious
agents,
investigating
spread
transmission
chains
outbreaks,
as
well
facilitating
development
effective
rapid
molecular
diagnostic
tests
contributing
to
hunt
treatments
vaccines.
The
ongoing
COVID-19
pandemic
poses
one
greatest
global
threats
modern
history
has
already
caused
severe
social
economic
costs.
efficient
methods
reconstruct
genomic
sequence
SARS-CoV-2,
etiological
agent
COVID-19,
fundamental
design
devise
measures
mitigate
diffusion
pandemic.
Diverse
approaches
can,
testified
by
number
available
sequences,
be
applied
SARS-CoV-2
genomes.
However,
each
technology
approach
its
own
advantages
limitations.
In
current
review,
we
will
provide
a
brief,
but
hopefully
comprehensive,
account
currently
platforms
methodological
We
also
present
an
outline
repositories
databases
that
access
data
associated
metadata.
Finally,
offer
general
advice
guidelines
appropriate
sharing
deposition
metadata,
suggest
more
standardized
integration
future
SARS-CoV-2-related
would
greatly
facilitate
struggle
against
this
new
pathogen.
hope
our
'vademecum'
production
handling
data,
contribute
objective.
BMC Infectious Diseases,
Год журнала:
2021,
Номер
21(1)
Опубликована: Янв. 13, 2021
Abstract
Background
Although
traditional
diagnostic
techniques
of
infection
are
mature
and
price
favorable
at
present,
most
them
time-consuming
with
a
low
positivity.
Metagenomic
next⁃generation
sequencing
(mNGS)
was
studied
widely
because
identification
typing
all
pathogens
not
rely
on
culture
retrieving
DNA
without
bias.
Based
this
background,
we
aim
to
detect
the
difference
between
mNGS
method,
explore
relationship
results
severity,
prognosis
infectious
patients.
Methods
109
adult
patients
were
enrolled
in
our
study
Shanghai
Tenth
People’s
Hospital
from
October
2018
December
2019.
The
results,
negative
predictive
values,
positive
false
rate,
pathogen
sample
types
analyzed
by
using
both
methods.
Then,
samples
clinical
information
93
infected
group
(ID)
collected.
According
whether
detected
pathogens,
ID
divided
into
67
cases
26
cases.
Peripheral
blood
leukocytes,
C-reactive
protein
(CRP),
procalcitonin
(PCT)
neutrophil
counts
measured,
concentrations
IL-2,
IL-4,
IL-6,
TNF-α,
IL-17A,
IL-10
INF-γ
serum
determined
ELISA.
correlation
detection
severity
illness,
hospitalization
days,
mortality
analyzed.
Results
assigned
(ID,
92/109,
84.4%),
non-infected
(NID,
16/109,
14.7%),
unknown
(1/109,
0.9%).
Blood
abundant
type
37
cases,
followed
bronchoalveolar
lavage
fluid
36
tissue,
sputum,
pleural
effusion,
cerebrospinal
(CSF),
pus,
bone
marrow
nasal
swab.
In
group,
majority
diagnosed
lower
respiratory
system
infections
(73/109,
67%),
bloodstream
infections,
effusion
central
nervous
infections.
sensitivity
significantly
higher
than
that
method
(67.4%
vs
23.6%;
P
<
0.001),
especially
(
=
0.002),
0.001)
sputum
0.037),
while
specificity
different
(68.8%
81.3%;
0.41).
number
hospitals
stays
28-day-motality
those
statistically
significant
0.05).
Age
multivariate
logistic
analyses
mNGS.
Conclusions
found
had
blood,
samples.
And
hospital
stay,
28-day-mortality,
which
means
nucleic
acid
sequences
may
be
potential
high-risk
factor
for
poor
has
value.
MNGS
should
used
more
early
diagnosis
future.
Frontiers in Microbiology,
Год журнала:
2020,
Номер
10
Опубликована: Янв. 14, 2020
Invasive
fungal
diseases
(IFDs)
present
an
increasing
global
burden
in
immunocompromised
and
other
seriously-ill
populations,
including
those
caused
by
pathogens
which
are
inherently
resistant
or
less
susceptible
to
antifungal
drugs.
Early
diagnosis
encompassing
accurate
detection
identification
of
the
causative
agent,
resistance
is
critical
for
optimum
patient
outcomes.
Many
molecular-based
diagnostic
approaches
have
good
clinical
utility
although
interpretation
results
should
be
according
context.
Where
IFD
differential
diagnosis,
panfungal
PCR
assays
allow
rapid
detection/identification
species
directly
from
specimens
with
specificity;
sensitivity
also
high
when
hyphae
seen
specimen
paraffin-embedded
tissue.
Aspergillus
on
blood
fractions
screening
high-
risk
haematology
patients
negative
positive
predictive
values
94%
70%,
respectively
two
obtained.
The
standardisation,
commercialisation
has
now
enabled
direct
comparison
between
laboratories
commercial
offering
simultaneous
common
azole
mutations.
Candida
not
as
well
standardised
only
FDA-approved
system
(T2Candida)
detecting
five
most
species;
whilst
T2Candida
outperforms
culture
candidaemia,
its
role
routine
diagnostics
defined.
There
growing
use
Mucorales-specific
detect
selected
genera
fractions.
Quantitative
real-time
Pneumocystis
jirovecii
PCRs
replaced
microscopy
immunofluorescent
stains
many
distinguishing
infection
may
problematic
non
HIV-infected
patients.
For
isolates,
DNA
barcoding
dual
loci
(ITS
TEF1α)
offer
optimal
accuracy
next
generation
sequencing
technologies
highly
discriminatory
analysis
genetic
diversity
outbreak
investigation,
drug
characterisation.
Advances
molecular
will
further
enhance
diagnostics.